All Articles

Chad Eberly's recent award highlights a shift in finance, where holistic support for SMBs is proving to be the new winning formula for growth.

Grupo Nutresa posted a 42% EBITDA surge, but a strong peso and rising financial costs pushed its reported net income into the red. What's behind the numbers?

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

South Jersey Industries offers to buy back $287.5M in notes for just 9 cents on the dollar, forcing a tough choice on bondholders. What's behind the move?

The industrial giant affirms its quarterly payout, a sign of stability for investors as it navigates a costly green transition and recent regulatory hurdles.

With its first patient enrolled and key EU approvals, Inhibikase pushes its PAH drug IKT-001 forward, balancing clinical hope with financial realities.

Andersen Group reports a 15.7% revenue jump, but IPO-related costs mask strong operational performance as the firm pursues aggressive global expansion.

As BranchOut Food preps its Q1 earnings call, investors watch to see if its patented tech and retail wins can deliver on the path to profitability.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

After two rejections and a dramatic financial restructuring, Atara Biotherapeutics has a clear path to resubmit its key cancer therapy to the FDA.

With cash to last into 2027, Bolt Biotherapeutics focuses all hope on its lead cancer drug, BDC-4182, ahead of crucial Q3 clinical data.

Resideo posted strong Q1 results with an 8% revenue jump to $1.91B, setting a positive stage for the planned separation of its ADI distribution arm.

Explora Journeys' new LNG-powered ship blends sustainable travel with rare events like a solar eclipse, aiming to redefine luxury cruising in Northern Europe.

A new national survey reveals a crisis of trust in the American workplace, with widespread fear silencing employees and ethical pressures on the rise.

Amid a falling stock price, renewable chemicals firm EcoSynthetix initiates a major share buyback, betting that the market undervalues its green innovation.

AWE 2026 honors XR legends, unveils groundbreaking art and research, and champions a future where spatial AI empowers, not replaces, humanity.

The California Science Center installs a massive 747 fuselage, offering a first look at the future Samuel Oschin Air and Space Center's grand vision.

Amity's retail AI agent beat 100+ firms to win a top award, proving that purpose-built vertical AI delivers more impact than generic chatbots.

Kansas City is making history by welcoming four-legged fans to the FIFA Fan Festival, blending global soccer excitement with a major pet adoption initiative.